Erica Palmisano, MD
Allergy & Immunology · Grandville, MINPI 1629367081
Payments from drug & device makers
Across 66 payments — averaging $19.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$259
- AstraZeneca$217
- Sanofi$126
- GSK$124
- Regeneron Healthcare Solutions, Inc.$109
- Dentsply Sirona Inc$73
- plus $354 from 9 others
What the payments were for
- Food & beverage$1,263100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 16 | $259 |
| AstraZeneca | 13 | $217 |
| Sanofi | 5 | $126 |
| GSK | 8 | $124 |
| Regeneron Healthcare Solutions, Inc. | 4 | $109 |
| Dentsply Sirona Inc | 1 | $73 |
| Alk-abello, Inc | 4 | $70 |
| Kaleo, Inc. | 3 | $59 |
| Covis Pharma GmbH | 3 | $54 |
| Shire North American Group Inc | 2 | $46 |
| CSL Behring | 2 | $35 |
| Teva Pharmaceuticals USA, Inc. | 2 | $35 |
| Pfizer | 1 | $27 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
| Optinose US, Inc. | 1 | $14 |
How this compares
$1,263 in reported general payments places this provider in the 35th percentile of 119 allergy & immunology providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XolairOmalizumab | 12 | $34,921 |
| BreynaBudesonide/Formoterol Fumarate | 12 | $3,439 |
| Ipratropium Bromide | 13 | $910 |
| Fluticasone Propionate | 11 | $197 |
Paid to pharmacies, not to this prescriber.
Other allergy & immunology in Grandville
- Jeffrey LefleinYpsilanti$7.9M
- Cem AkinNorthville$3M
- Alan BaptistAnn Arbor$2.5M
- Suresh AnneFlint$1.1M
- Steven StrykCanton$949K
- Hassan NasirWest Branch$736K
- Theodore KelbelGrand Rapids$695K
- Rajan RavikumarBrighton$661K
- Georgiana SandersAnn Arbor$607K
- Nicholas HartogGrand Rapids$581K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.